ArticleBiomedical optics express2024
DFC-Net: a dual-path frequency-domain cross-attention fusion network for retinal image quality assessment.
Article in Biomedical optics express, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal image quality assessment (RIQA) is crucial for diagnosing various eye diseases and ensuring the accuracy of diagnostic analyses based on retinal fundus images. Traditional deep convolutional neural networks (CNNs) for RIQA face challenges such as over-reliance on RGB image brightness and difficulty in differentiating closely ranked image quality categories. To address these issues, we introduced the Dual-Path Frequency-domain Cross-attention Network (DFC-Net), which integrates RGB images and contrast-enhanced images using contrast-limited adaptive histogram equalization (CLAHE) as dual inputs. This approach improves structure detail detection and feature extraction. We also incorporated a frequency-domain attention mechanism (FDAM) to focus selectively on frequency components indicative of quality degradations and a cross-attention mechanism (CAM) to optimize the integration of dual inputs. Our experiments on the EyeQ and RIQA-RFMiD datasets demonstrated significant improvements, achieving a precision of 0.8895, recall of 0.8923, F1-score of 0.8909, and a Kappa score of 0.9191 on the EyeQ dataset. On the RIQA-RFMiD dataset, the precision was 0.702, recall 0.6729, F1-score 0.6869, and Kappa score 0.7210, outperforming current state-of-the-art approaches.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.